Breaking News

AAPS, Catalent Drug Delivery Institute Launch Third Annual Competition

By Kristin Brooks | January 24, 2014

Aims to accelerate research and drug delivery technologies

The Catalent Applied Drug Delivery Institute in collaboration with the American Association of Pharmaceutical Scientists (AAPS), has launched the “3rd Annual Global Academic Competition for Life Science Leaders of Tomorrow.” The program aims to encourage students’ interest and increase their knowledge of applied drug delivery technologies, and it is now open for entries. More information is available at www.drugdeliveryinstitute.com/global-academic-competition
 
Eligible university students enrolled in graduate programs focused on the pharmaceutical sciences, industrial pharmacy, drug delivery, drug development or related disciplines, will compete for one of five prizes of $2,000, a complimentary, one-year AAPS membership, and the opportunity to have their submissions published by Catalent in the Institute and/or industry publications.
 
Article entries should cover topics such as drug development, improving therapeutic profiles and bioavailability, pre-formulation, drug delivery innovation in inhalation, biologics, lipid-based systems, crossing the blood-brain barrier, or on the delivery of drugs in certain patient groups such as pediatrics.  The deadline for entries is March 28th, 2014.
 
“The Global Academic Competition supports the mission of The Catalent Applied Drug Delivery Institute to foster education, collaboration, and adoption of drug delivery technologies to develop better treatments for patients,” said Terry Robinson, executive director of the Institute.  “We are delighted that AAPS is co-sponsoring the competition this year, and with their reach to 2,500 student and postdoctoral Fellow members, and almost 100 student chapters in 35 countries around the globe, we look forward to expanding the number of participating universities.”
blog comments powered by Disqus
  • Top 25 Pharma and Biopharma Report

    Top 25 Pharma and Biopharma Report

    July 20, 2015
    (Based on 2014 Sales, in $U.S. Millions)

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important